|
Jun 22
|
A Billionaire Trump Supporter Is Buying These Two Stocks
|
|
Jun 14
|
Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds
|
|
Jun 10
|
Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement
|
|
May 9
|
Bausch + Lomb receives CE mark for Luxlife intraocular lens
|
|
May 8
|
Bausch + Lomb gains CE Mark approval for full range of vision intraocular lens
|
|
May 7
|
Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential
|
|
May 6
|
Bausch Health Up 3.5% In US Premarket As Says New Analysis Suggests efficacy of Xifaxan
|
|
May 6
|
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
|
|
Feb 16
|
Bausch Health Companies Inc. (NYSE:BHC) Could Be Less Than A Year Away From Profitability
|
|
Feb 14
|
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
|
|
Feb 12
|
Earnings Preview: Bausch Health (BHC) Q4 Earnings Expected to Decline
|
|
Feb 10
|
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
|
|
Oct 9
|
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
|
|
Oct 9
|
Bausch Health Companies Inc (BHC) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
|
|
Oct 8
|
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
|
|
Jul 25
|
Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?
|
|
Jul 24
|
Bausch Health Stock Swings Wildly as it Addresses Report It's Considering Bankruptcy
|
|
Jul 24
|
Bausch Health Responds to Market Rumors
|
|
Jul 24
|
Bausch Health tanks 23.3% on unconfirmed report of bankruptcy filing
|
|
Jul 24
|
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
|